Errata: Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint Analysis The classification of AML and therapeutic options are now largely driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback